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ABSTRACT
The time from the start of incubation to a positive reading of blood cultures (time-to-positivity; TTP) is
related to the concentration of bacteria in blood. Information concerning the correlation of TTP with
clinical parameters, and its usefulness as a prognostic factor in patients with Escherichia coli bacteraemia,
is limited. To investigate the relationship of TTP to clinical parameters, 459 cases of monomicrobial
E. coli bloodstream infections from a single institution between 1997 and 2005 were reviewed. All cases
involved patients who were not undergoing antibiotic treatment at the time of blood sampling. The
in-hospital mortality rate was 6.3%. Median TTP was signiﬁcantly shorter for patients who died than for
those who survived (9.7 h, inter-quartile range 7.85–11.05 h vs. 11.2 h, inter-quartile range 10.1–11.4 h;
p <0.001). Patients with TTP in the lowest quartile were more likely to be female, to have a non-urinary
tract or an unknown origin of bacteraemia, to have severe sepsis or shock, and to subsequently die. In a
multivariable Cox regression model, the hazard ratio for death from any cause for patients with a short
TTP was 3.13 (95% CI 1.28–7.64; p 0.01). TTP in patients with E. coli bacteraemia provides prognostic
information beyond that provided by the presence of haematological illness, a Charlson score ‡3, a
non-urinary tract origin of bacteraemia, and the presence of severe sepsis or shock.
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INTRODUCTION
Escherichia coli is the most common cause of
bloodstream infection involving Gram-negative
bacteria [1–3]. Current knowledge concerning the
primary site of infection, clinical presentation,
epidemiology and prognostic factors of E. coli
bloodstream infections is limited and mostly
somewhat dated [4–9]. Such information is used
in daily practice for predicting the origin of
bacteraemia and the outcome of patients with
E. coli bloodstream infection, but its sensitivity
and speciﬁcity is limited and other prognostic
parameters would be useful.
Bacterial blood concentration is associated with
the prognosis for patients with bacteraemia
caused by certain microorganisms [10–16], yet
quantitative blood cultures are not performed
routinely in clinical practice. The time from the
start of incubation to a positive reading of blood
cultures is related to the concentration of bacteria
[17,18] and fungi [19] in blood. Recent data
suggest that the time-to-positivity (TTP) of blood
cultures may be associated with prognosis [9,20–
22], although information for patients with E. coli
bacteraemia concerning the correlation of TTP
with clinical parameters is quite limited [9].
Accordingly, the present study investigated the
TTP of E. coli bacteraemia and its relationship to
clinical parameters and prognosis.
PATIENTS AND METHODS
Hospital setting and patients
The study was conducted at the Hospital Sierrallana, a 250-bed
teaching hospital in Torrelavega, Spain, with c. 8000
admissions annually, which serves a population of 160 000
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inhabitants. Approximately 1800 blood cultures are performed
annually at this hospital. Between January 1997 and December
2005, patients with E. coli bacteraemia were identiﬁed from the
microbiology laboratory database and their charts were
reviewed retrospectively with the aid of a standardised data
collection form. Data collected included age, gender, previous
surgery, antibiotic therapy, duration of hospitalisation before
the onset of bacteraemia, presence of severe sepsis or shock,
white blood cell count, haemoglobin concentration, plasma
creatinine concentration, presence of co-morbidities (diabetes,
chronic obstructive pulmonary disease, cirrhosis, previous
stroke, cardiac failure, neoplasm, chronic renal failure, immu-
nosuppression or haematological illness) and in-hospital
mortality.
Deﬁnitions
A localised focus of E. coli infection was considered to be the
source or primary focus of bacteraemia. Bacteraemia was
considered to be nosocomial if it appeared ‡48 h after
admission and no evidence of infection was present upon
admission. Immunosuppression was deﬁned as the presence
of neutropenia, or infection with human immunodeﬁciency
virus, or treatment with immunosuppressive agents.
Co-morbidities were assessed using the Charlson co-morbidity
score [23]. Sepsis, severe sepsis and septic shock were deﬁned
as proposed by Bone et al. [24]. Therapy was judged as
adequate or inadequate, based on the in-vitro susceptibility of
the isolated organism and whether the antibiotic treatment
was initiated within 24 h of blood sampling.
Blood cultures
The common practice for blood cultures at Sierallana Hospi-
tal is to take 20 mL of venous blood and inoculate it in equal
parts into one aerobic blood culture bottle (BacT ⁄ALERT FA
aerobic; bioMe´rieux, Durham, NC, USA) and one anaerobic
blood culture bottle (BacT ⁄ALERT FN; bioMe´rieux). Blood
from a peripheral vein was sampled by nurses, three times at
intervals of 30 min. On a 24-h basis, the blood culture bottles
were sent to the microbiology laboratory, immediately loaded
into the blood culture instrument (BacT ⁄ALERT microbial
detection system; bioMe´rieux), and cultured for 5 days. The
BacT ⁄ALERT system tests for CO2 production and records
the time interval between the addition of each blood culture
bottle to the system and the detection of microbial growth
(deﬁned as TTP). No antibiotic removal device was used for
the blood cultures of patients treated previously with anti-
biotics. When multiple cultures were positive, the shortest
TTP was selected for the analysis. Neither the volume of
blood cultured nor the time interval between obtaining
the blood for culture and incubation of the bottles was
recorded.
Statistical analysis
Baseline characteristics of the study patients, grouped
according to quartiles of TTP, are presented as percentages
for dichotomous variables and as medians with inter-quartile
ranges (IQRs) for continuous variables. Baseline characteris-
tics were compared among quartiles using the chi-square
test for discrete variables and the Wilcoxon or Kruskal–
Wallis rank sum test for continuous variables, as appropri-
ate. The non-parametric correlation (Spearman’s q coefﬁ-
cient) was used to analyse the association between two
variables. A stepwise logistic regression analysis was used to
control the effects of confounding variables. Survival curves
were generated by means of Kaplan–Meier estimates, and
differences in survival were compared using the log-rank
test. To control for confounders, the multivariable Cox
model was ﬁtted. Inclusion of the variables in the model
was determined according to their signiﬁcance in the
univariate analysis. Relative risks and 95% CIs were calcu-
lated as hazard ratios derived from the Cox proportional-
hazards regression model, including variables associated
with death in the univariate model. The level of signiﬁcance
was set at p <0.05. Statistical analysis was performed using
SPSS software for Windows, v.12 (SPSS Inc., Chicago, IL,
USA).
RESULTS
Patients and blood cultures
During the study period, E. coli bacteraemia was
detected in 555 patients admitted to the hospital.
Excluded from the study were 38 patients with
polymicrobial bloodstream infections, 59 patients
receiving treatment with antibiotics when blood
was sampled, and two patients for whom TTP
was not available; neither of the latter two
patients had severe sepsis or septic shock or died.
For the remaining 459 patients included in the
analysis, the number of blood culture bottles
inoculated for each episode of bacteraemia was
six in 424 cases, ﬁve in two cases, four in 18 cases,
three in one case and two in 14 cases.
Patients with E. coli bacteraemia were aged 15–
98 years (median 77 years). Fifty (10.8%) patients
had severe sepsis, and ﬁve (1.1%) had septic
shock at presentation. Twenty-nine (6.3%)
patients died during hospitalisation after 8.9 ±
8.6 days (range 0–29 days) following the onset of
bacteraemia. A trend towards a lower incidence
of severe sepsis or shock among male patients
(9.4% vs. 14.2%, p 0.09) was detected. Demo-
graphical and clinical characteristics of these
patients are listed in Table 1.
Time-to-positivity
TTP was available for 459 patients and 1659 blood
culture bottles. A correlation was found between
the mean TTP of each series and the shortest TTP
of the blood culture bottles of each patient (q 0.8,
p <0.0001). The median TTP was 11.2 h (range 1–
115.2 h). In patients with more than one positive
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bottle, the median maximal difference of the TTP
among the blood culture bottles of each series was
1.1 h (range 0–145.3 h), and the median difference
in TTP between aerobic and anaerobic blood
culture bottles was 0 h (range )17 to 44.5 h). A
signiﬁcant negative correlation was found be-
tween the shortest TTP for each episode of
bacteraemia and the number of positive blood
culture bottles from each episode (q )0.48,
p <0.0001) (Fig. 1).
Patients were divided into subgroups accord-
ing to quartiles of the shortest TTP for each
episode of bacteraemia. Patients with TTP in the
lowest quartile were less likely to be male
(OR 0.62; 95% CI 0.4–0.95), but were more likely
to experience severe sepsis or shock (OR 5.333;
95% CI 2.97–9.59), to have a non-urinary tract
origin of bacteraemia (OR 2.1; 95% CI 1.38–3.23),
to experience an unknown origin of bacteraemia
(OR 2.12; 95% CI 1.2–3.76), to require treatment
in an intensive care unit (OR 4.85; 95% CI 1.93–
12.18) or to die (OR 4.2; 95% CI 1.95–9.02).
Table 1 shows the baseline characteristics
grouped according to quartiles of TTP. After
adjusting for these variables in a logistic regres-
sion analysis, male gender was still associated
with a TTP in the lowest quartile. Receiver
operator curve analysis revealed that a TTP of
10.95 h was associated with the best sensitivity
and speciﬁcity for predicting a urinary tract origin
of the bacteraemia (61% and 67%, respectively).
Relationship between TTP and mortality
The median TTP was signiﬁcantly shorter for
patients who died than for those who survived
(9.7 h, IQR 7.85–11.05 h vs. 11.2 h, IQR 10.1–
11.4 h; p <0.001). Receiver operator curve analysis
revealed that a TTP of 10.25 h was associated with
the best sensitivity and speciﬁcity for predicting
death (71% and 65.5%, respectively). A TTP value
below this cut-off point was deﬁned as ‘short
TTP’. Univariate analysis revealed that an in-
creased Charlson score, the presence of dementia,
Table 1. Baseline clinical character-
isticsa of 459 patients with Escheri-
chia coli bacteraemia, grouped
according to quartiles of time-to-
positivity (TTP)
Characteristic
Overall
n = 459
1st quartile
n = 114
2nd quartile
n = 114
3rd quartile
n = 116
4th quartile
n = 115 p
TTP (h) 1–115.2 1–9.8 9.9–11.1 11.2–12.2 12.3–115.2
Male (%) 49.2 40.4 49.1 47.4 60 0.028
Age >65 years (%) 78.4 73.7 81.6 76.7 81.7 0.37
Nosocomial bacteraemia (%) 10.9 11.4 11.4 7.8 13 0.62
Co-morbidity (%)
Neoplasm (%) 10.2 8.8 14.9 7.8 9.6 0.28
Dementia (%) 8.7 8.8 3.5 11.2 11.3 0.12
Immunosuppression (%) 3.9 6.1 6.1 0 3.5 0.05
Chronic renal failure (%) 3.3 2.6 0 5.2 5.2 0.08
Origin of infection
Urinary tract (%) 56.6 42.1 57 63.8 63.5 0.002
Biliary tract (%) 19.8 23.7 28.9 14.7 12.2 0.004
Unknown (%) 12.9 20.2 7.0 12.1 12.2 0.03
Intra-abdominal (%) 5.4 5.3 3.5 6 7 0.7
Respiratory tract (%) 1.7 2.6 1.8 1.7 0.9 0.79
Presentation
Altered consciousness (%) 12 14 14.9 6.9 12.2 0.24
Severe sepsis or shock (%) 12 27.2 7.9 7.8 5.2 <0.001
Outcome
Required ICU treatment 4.4 10.5 2.6 2.6 1.7 0.003
Length of stayb (days) 9 (6–14) 10 (6–18.3) 9 (7–12) 8 (6–12) 9 (6–14.2) 0.065
Death (%) 6.3 14 5.3 3.4 2.6 0.001
aData are median (inter-quartile range) unless otherwise indicated.
bAfter bacteraemia for surviving patients.
ICU, intensive care unit.
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Fig. 1. Correlation between the shortest time-to-positivity
(TTP) of each episode of bacteraemia and the number of
positive blood culture bottles from each episode for
patients with Escherichia coli bacteraemia.
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the presence of any co-morbidity, a non-urinary
tract origin of bacteraemia, a pulmonary origin of
bacteraemia, the presence of severe sepsis or
shock, decreased consciousness, an absence of
fever and a short TTP were all associated
with death (Table 2). Patients who survived
with a short TTP tended to have a longer
hospital stay following the episode of bacte-
raemia (13.59 ± 11.17 days vs. 10.61 ± 7.16 days,
p 0.067).
A stratiﬁed univariate analysis showed that a
short TTP was also associated with death among
patients whose bacteraemia was of non-urinary
tract origin (OR 4.24; 95% CI 1.57–11.46), or who
were without severe sepsis or shock (OR 4.87;
95% CI 1.72–13.73), or who had a Charlson score
£3 (OR 2.52; 95% CI 0.95–6.71).
In a Cox regression model, the unadjusted
hazard ratio for the death of patients with a short
TTP, compared with the remaining patients, was
4.36 (95% CI 2.03–9.37; p <0.0001) (Fig. 2). In a
multivariable Cox regression model, variables
associated with death were a short TTP, demen-
tia, a Charlson score ‡3, the presence of severe
sepsis or shock, and non-urinary tract origin of
bacteraemia (Table 3).
DISCUSSION
The present study analysed the relationship
between TTP and various clinical parameters
among patients with E. coli bacteraemia. E. coli
was found to grow faster in blood cultures from
females, from those patients whose bacteraemia
was of non-urinary tract or unknown origin, from
cases of severe sepsis or shock, and from patients
who died. More importantly, a short TTP was
found to be an independent risk-factor for death.
The study revealed that TTP provides prognostic
information concerning mortality from all causes
for patients with E. coli bacteraemia, independent
of other prognostic clinical parameters, thus
providing information beyond that supplied by
clinical variables. Several previous studies have
suggested that the concentration of bacteria in
Table 2. Variables revealed by uni-
variate analysis to be associated
with all-cause hospital mortality
among patients with Escherichia coli
bacteraemia
Died
n (%)
Survived
n (%) OR (95% CI) p
Demographics
Male 15 (51.7) 211 (49.1) 1.11 (0.52–2.36) 0.47
Age >65 years 23 (79.3) 337 (78.4) 1.06 (0.42–2.67) 0.56
Nosocomial bacteraemia 2 (6.9) 48 (11.2) 0.59 (0.14–2.56) 0.37
Adequate empirical treatment 24 (82.8) 367 (85.5) 0.81 (0.3–2.21) 0.43
Co-morbidity
Neoplasm 3 (10.3) 44 (10.2) 1.01 (0.29–3.48) 0.58
Dementia 7 (24.1) 33 (7.7) 3.83 (1.52–9.62) 0.008
Immunosuppression 3 (10.3) 15 (3.5) 3.19 (0.87–11.73) 0.1
Chronic renal failure 3 (10.3) 12 (2.8) 4.02 (1.07–15.13) 0.06
Charlson index (mean ± SD) 1.86 ± 2.1 0.91 ± 1.58 0.01
Origin of infection
Urinary tract 8 (27.6) 252 (58.6) 0.27 (0.12–0.62) 0.001
Biliary tract 4 (13.8) 87 (20.2) 0.63 (0.21–1.86) 0.28
Unknown 7 (24.1) 52 (12.1) 2.31 (0.94–5.68) 0.06
Intra-abdominal 3 (10.3) 22 (5.1) 2.14 (0.6–7.62) 0.2
Respiratory tract 3 (10.3) 5 (1.2) 9.81 (2.22–43.31) 0.01
Manifestations of bacteraemia
Decreased consciousness 10 (34.5) 45 (10.5) 4.5 (1.97–10.28) 0.001
Severe sepsis or shock 13 (44.8) 42 (9.8) 7.51 (3.4–16.67) <0.001
Short TTPa 19 (65.5) 125 (29.1) 4.64 (2.1–10.25) <0.001
aTime-to-positivity of <10.25 h.
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Fig. 2. Adjusted estimates of overall survival for patients
with Escherichia coli bacteraemia, according to time-to-
positivity (TTP). The survival estimates have been adjusted
for the presence of a Charlson index ‡3, urinary tract or
pulmonary origin of bacteraemia, the presence of severe
sepsis or shock, and decreased consciousness (p 0.001 by
the log-rank test for the overall comparison among the
groups).
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blood is related to outcome in patients with
bacteraemia [10–16], and in-vitro studies have
revealed a correlation between TTP and bacterial
concentrations in blood [17–19]. TTP is automat-
ically measured by continuously monitoring
blood culture systems, and is considered to be a
surrogate marker of bacterial concentrations in
blood [18,25]. Moreover, the difference between
the TTP of blood cultures drawn through a central
venous catheter and that of those drawn from a
peripheral vein is highly diagnostic of catheter-
related bloodstream infection in patients with
long-term catheters [18,25]. Recent studies have
suggested that there is a relationship between
TTP and outcome and the origin of bacteraemia in
infections caused by Streptococcus pneumoniae [22],
Staphylococcus aureus [20,21] and E. coli [9]. In
these studies, TTP was related to the presence of
severe sepsis or shock, the origin of bacteraemia,
and outcome [9,20–22]. In view of these ﬁndings,
TTP is an attractive candidate for an easy-to-
measure laboratory prognostic factor for patients
with bacteraemia.
Only one previous study has analysed TTP for
patients with E. coli bacteraemia, and reported
that a TTP of £7 h was associated with mortality;
however, this study involved a relatively small
sample, and failed to select a TTP cut-off value
based on the best sensitivity and speciﬁcity for
predicting death. In addition, >20% of the
patients included were receiving antibiotic treat-
ment when blood was sampled, which could
have altered the TTP [9]. Despite its usefulness
as a prognostic tool, TTP is somewhat limited in
that it has a sub-optimal sensitivity in predicting
death, and because factors other than the con-
centration of bacteria in blood can inﬂuence its
value, including the precise microorganisms
cultured [26–30], the automated blood culture
system used [26–28], and the presence of anti-
microbial agents in the blood [31,32], all of which
can make the use of a standard cut-off TTP in
clinical practice difﬁcult.
The present data pose several questions. First,
no satisfactory explanation exists for the relation-
ship between gender and TTP. A second question
concerns the relationship between TTP, urinary
tract infection and outcome. Several studies have
revealed that a urinary tract origin for patients
with bacteraemia is associated with lower mor-
tality [3,33]. A potential association between
urinary tract infection and a lower concentration
of bacteria in blood is supported by the results of
the present study, which may explain, at least in
part, the better outcome of these patients.
The present study had several limitations.
Certain patient characteristics, e.g., the presence
of neutropenia or immunosuppression, might
also be important determinants of the severity of
bacteraemia. The small number of patients with
these conditions precluded a meaningful assess-
ment of these potential variables. Additional
studies are necessary to clarify the effect of the
immune status on TTP. Another limitation is that
neither the time between blood sampling and
culture, nor the volume of blood drawn for
culture, were recorded, although it is likely that
differences in blood volume between culture
bottles were random. The inﬂuence of these
factors, as well as the effect of the system used
for blood cultures, on TTP values complicates
extrapolation of the results to other settings. It is
also unclear whether a correction of TTP accord-
ing to the blood volume in each culture
bottle might improve the relationship of TTP to
outcome. Nevertheless, the study supports the
usefulness of TTP as a tool for prognosis and for
deﬁning the origin of bacteraemia in patients with
E. coli bloodstream infection. Further studies are
required to deﬁne its usefulness and the optimal
cut-off points for bloodstream infections caused
by other microorganisms.
REFERENCES
1. Diekema D, Pfaller MA, Jones R et al. Survey of blood-
stream infections due to gram-negative bacilli: frequency
of occurrence and antimicrobial susceptibility of isolates
collected in the United States, Canada, and Latin America
for the SENTRY Antimicrobial Surveillance Program,
1997. Clin Infect Dis 1999; 29: 595–607.
Table 3. Hazard ratios for death from any cause in the
multivariate model
Adjusted hazard
ratios (95% CI)a p
Dementia 2.88 (1.18–7.04) 0.021
Charlson index ‡3 5.61 (2.52–12.5) 0.02
Non-urinary tract origin 3.31 (1.42–7.74) 0.006
Short TTPb 2.98 (1.29–6.87) 0.06
aRelative risk and 95% CIs were calculated as hazard ratios derived from the Cox
proportional-hazards regression model for overall mortality. Co-variates included
in the initial model were the presence of dementia, a Charlson index ‡3, non-
urinary tract origin of bacteraemia, pulmonary origin of bacteraemia, presence of
severe sepsis or shock, decreased consciousness, and short time-to-positivity (TTP).
Excluding, individually, the presence of dementia, the presence of severe sepsis or
shock, and altered consciousness from the model did not change the prognostic
value of TTP.
bTTP of <10.25 h.
Peralta et al. Time-to-positivity with E. coli bacteraemia 1081
 2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 1077–1082
2. Javaloyas MD, Garcia-Somoza D, Gudiol F. Epidemiology
and prognosis of bacteremia: a 10 years study in a com-
munity hospital. Scand J Infect Dis 2002; 34: 436–441.
3. Weinstein MP, Towns ML, Quartey S et al. The clinical
signiﬁcance of positive blood culture in the 1990s: a pro-
spective comprehensive evaluation of the microbiology,
epidemiology, and outcome of bacteremia and fungemia
in adults. Clin Infect Dis 1997; 24: 584–602.
4. Gransden WR, Eykyn SJ, Phillips I, Rowe B. Bacteremia
due to Escherichia coli: a study of 861 episodes. Rev Infect
Dis 1990; 12: 1008–1018.
5. Olesen B, Kolmos HJ, Orskov F, Orskov I, Gottschau A.
Bacteraemia due to Escherichia coli in a Danish univer-
sity hospital, 1986–1990. Scand J Infect Dis 1995; 27:
253–257.
6. Javaloyas M, Garcia-Somoza D, Gudiol F. Bacteremia due
to Escherichia coli: epidemiological analysis and sensitivity
to antibiotics in a county hospital. Med Clin (Barc) 2003;
120: 125–127.
7. Vazquez F, Mendoza MC, Viejo G, Mendez FJ. Survey of
Escherichia coli septicemia over a six-year period. Eur J Clin
Microbiol Infect Dis 1992; 11: 110–117.
8. Kuikka A, Sivonen A, Emelianova A, Valtonen VV. Prog-
nostic factors associated with improved outcome of
Escherichia coli bacteremia in a Finnish university hospital.
Eur J Clin Microbiol Infect Dis 1997; 16: 125–134.
9. Martinez JA, Soto S, Fabrega A et al. Relationship of phy-
logenetic background, bioﬁlm production, and time to
detection of growth in blood culture vials with clinical
variables and prognosis associated with Escherichia coli
bacteremia. J Clin Microbiol 2006; 44: 1468–1474.
10. Santosham M, Moxon ER. Detection and quantitation of
bacteremia in childhood. J Pediatr 1977; 91: 719–721.
11. Bell LM, Alpert G, Campos JM, Plotkin SA. Routine
quantitative blood cultures in children with Haemophilus
inﬂuenzae or Streptococcus pneumoniae bacteremia. Pediatrics
1985; 76: 901–904.
12. Sullivan TD, LaScolea LJ, Neter E. Relationship between
the magnitude of bacteremia in children and the clinical
disease. Pediatrics 1982; 69: 699–702.
13. Sullivan TD, LaScolea LJ. Neisseria meningitidis bacteremia
in children: quantitation of bacteremia and spontaneous
clinical recovery without antibiotic therapy. Pediatrics
1987; 80: 63–67.
14. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-
negative bacteremia. III. Reassessment of etiology, epide-
miology and ecology in 612 patients. Am J Med 1980; 68:
332–343.
15. Marshall GS, Bell LM. Correlates of high grade and low
grade Haemophilus inﬂuenzae bacteremia. Pediatr Infect Dis J
1988; 7: 86–90.
16. La Scolea LJ, Dryja D. Quantitation of bacteria in cere-
brospinal ﬂuid and blood of children with meningitis
and its diagnostic signiﬁcance. J Clin Microbiol 1984; 19:
187–190.
17. Haimi-Cohen Y, Vellozzi EM, Rubin LG. Initial concen-
tration of Staphylococcus epidermidis in simulated pediatric
blood cultures correlates with time to positive
results with the automated, continuously monitored
BACTEC blood culture system. J Clin Microbiol 2002; 40:
898–901.
18. Blot F, Schmidt E, Nitenberg G et al. Earlier positivity of
central-venous- versus peripheral-blood cultures is highly
predictive of catheter-related sepsis. J Clin Microbiol 1998;
36: 105–109.
19. George BJ, Horvath LL, Hospenthal DR. Effect of inocu-
lum size on detection of Candida growth by the BACTEC
9240 automated blood culture system using aerobic and
anaerobic media. J Clin Microbiol 2005; 43: 433–435.
20. Khatib R, Riederer K, Saeed S et al. Time to positivity in
Staphylococcus aureus bacteremia: possible correlation with
the source and outcome of infection. Clin Infect Dis 2005;
41: 594–598.
21. Marra AR, Edmond MB, Forbes BA, Wenzel RP, Bearman
GM. Time to blood culture positivity as a predictor of
clinical outcome of Staphylococcus aureus bloodstream
infection. J Clin Microbiol 2006; 44: 1342–1346.
22. Peralta G, Rodriguez-Lera MJ, Garrido JC, Ansorena L,
Roiz MP. Time to positivity in blood cultures of adults
with Streptococcus pneumoniae bacteremia. BMC Infect Dis
2006; 6: 79.
23. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new
method of classifying prognostic comorbidity in longitu-
dinal populations: development and validation. J Chronic
Dis 1987; 40: 373–378.
24. Bone RC, Sprung CL, Sibbald WJ. Deﬁnitions for sepsis
and organ failure. Crit Care Med 1992; 20: 724–726.
25. Malgrange VB, Escande MC, Theobald S. Validity of
earlier positivity of central venous blood cultures in
comparison with peripheral blood cultures for diagnosing
catheter-related bacteremia in cancer patients. J Clin
Microbiol 2001; 39: 274–278.
26. Cockerill FR, Reed GS, Hughes JG et al. Clinical com-
parison of BACTEC 9240 plus aerobic ⁄F resin bottles and
the isolator aerobic culture system for detection of
bloodstream infections. J Clin Microbiol 1997; 35: 1469–
1472.
27. Murray PR, Hollick GE, Jerris RC, Wilson ML. Multicenter
comparison of BACTEC 9050 and BACTEC 9240 blood
culture systems. J Clin Microbiol 1998; 36: 1601–1603.
28. Alpern ER, Alessandrini EA, Bell LM, Shaw KN, McGo-
wan KL. Occult bacteremia from a pediatric emergency
department: current prevalence, time to detection, and
outcome. Pediatrics 2000; 106: 505–511.
29. Vigano EF, Vasconi E, Agrappi C, Clerici P. Use of simu-
lated blood cultures for time to detection comparison be-
tween BacT ⁄ALERT and BACTEC 9240 blood culture
systems. Diagn Microbiol Infect Dis 2002; 44: 235–240.
30. Norris CF, Smith-Whitley K, McGowan KL. Positive blood
cultures in sickle cell disease: time to positivity and clinical
outcome. J Pediatr Hematol Oncol 2003; 5: 390–395.
31. Vigano EF, Vasconi E, Agrappi C, Clerici P, Melloni P.
Use of simulated blood cultures for antibiotic effect on
time to detection of the two blood culture systems Bac-
T ⁄ALERT and BACTEC 9240. New Microbiol 2004; 27:
235–248.
32. Flayhart D, Borek AP, Wakeﬁeld T, Dick J, Carroll KC.
Ability of BD BACTEC PLUS blood culture bottles versus
BacT ⁄Alert FA blood culture bottles to detect bacterial
pathogens in samples containing therapeutic levels of
antibiotics. J Clin Microbiol 2007; 45: 816–821.
33. Blot S, Vandewoude K, De Bacquer D, Colardyn F.
Nosocomial bacteremia caused by antibiotic-resistant
gram-negative bacteria in critically ill patients: clinical
outcome and length of hospitalization. Clin Infect Dis 2002;
34: 1600–1606.
1082 Clinical Microbiology and Infection, Volume 13 Number 11, November 2007
 2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 1077–1082
